SCHEMBL4695301

SCHEMBL4695301

CC(=O)C(=O)Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6004144 0.78
SCHEMBL1332091 0.78
SCHEMBL35161 0.78
SCHEMBL9818733 0.78
SCHEMBL15216106 0.76 TSHR (0.50)
Fluoride SCHEMBL28061709 0.74
Water SCHEMBL27537799 0.74
SCHEMBL29506885 0.74
Hydrochloric Acid SCHEMBL27605334 0.74
SCHEMBL28894528 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117777051-B Synthesis method of 2-bromo-5-chlorothiazole-4-carboxylate 山西永津集团有限公司 2024-07-02 CN disclosed
CN-117777051-A Synthesis method of 2-bromo-5-chlorothiazole-4-carboxylate 山西永津集团有限公司 2024-03-29 CN disclosed
US-8501785-B2 Salts of benzimidazolyl pyridyl ethers and formulations thereof NOVARTIS AG (CH) 2013-08-06 US disclosed
US-20120308651-A1 SALTS OF BENZIMIDAZOLYL PYRIDYL ETHERS AND FORMULATIONS THEREOF NOVARTIS AG 2012-12-06 US disclosed
EP-1966222-A2 PYRAZOLOTHIAZOLE PROTEIN KINASE MODULATORS SGX Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed
WO-2007059341-A2 PYRAZOLOTHIAZOLE PROTEIN KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2007-05-24 WO disclosed